Description

Laviceftra-1.5gm Injection
Composition: Ceftriaxone 1000 mg + Sulbactam 500 mg

Laviceftra-1.5gm Injection is a powerful combination antibiotic developed by Lavish Biotech, containing Ceftriaxone (a broad-spectrum cephalosporin antibiotic) and Sulbactam (a beta-lactamase inhibitor). This combination is highly effective against a wide range of resistant bacterial infections.

It is widely prescribed for the treatment of respiratory tract infections, urinary tract infections, intra-abdominal infections, skin infections, sepsis, and post-surgical infections. Administered via intravenous (IV) or intramuscular (IM) routes, Laviceftra-1.5gm provides quick relief and ensures effective bacterial eradication.

✅ Key Benefits

• Broad-spectrum action against resistant bacteria.

• Effective for severe respiratory, urinary, and abdominal infections.

• Prevents bacterial resistance due to the presence of Sulbactam.

• Fast-acting and reliable for hospital and clinical use.

• Trusted antibiotic for critical care management.

💉 How to Use

• Administered via IV (intravenous) infusion or IM (intramuscular) injection.

• Dosage depends on infection severity and patient’s condition.

• Always to be given under the supervision of a qualified healthcare professional.

⚠️ Safety Information

• For hospital/clinical use only.

• Not to be self-administered.

• Store in a cool, dry place away from direct sunlight.

• Complete the prescribed course for maximum effectiveness.

🌟 Lavish Biotech Advantage

Laviceftra-1.5gm Injection is manufactured with strict quality control standards to ensure safety and efficacy. As a leading Third Party Manufacturing Company in Panchkula, Lavish Biotech also provides business growth opportunities through Best PCD Pharma Franchise in Panchkula, helping partners establish a strong presence in the pharma sector.

FAQs

Q1. What is Laviceftra-1.5gm Injection used for?
It is used to treat severe bacterial infections such as respiratory infections, urinary tract infections, intra-abdominal infections, sepsis, and post-surgical infections.

Q2. How is Laviceftra-1.5gm Injection given?
It is administered through IV infusion or IM injection by a healthcare professional.

Q3. Can this injection be self-administered?
No, it must be given by a trained doctor or nurse in a clinical setting.

Q4. Are there any side effects of Laviceftra Injection?
Some patients may experience mild pain at the injection site, diarrhea, or nausea. Serious side effects are rare but should be reported immediately.

Q5. Who manufactures Laviceftra-1.5gm Injection?
It is manufactured by Lavish Biotech, a reputed pharma company known for high-quality formulations, third-party manufacturing, and monopoly PCD franchise opportunities in Panchkula.